Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept Long-Term Extension in Ankylosing Spondylitis
NCT00444340Phase 4Completed
- Sponsor
- Pfizer
- Start
- Apr 2004
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 4 trial of etanercept in ankylosing spondylitis (AS), sponsored by Pfizer. Started Apr 2004; status: completed.
02
Drugs
etanercept
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT00444340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00444340.